Microbial LPS enhances PD-1 therapy during chronic LCMV infection

被引：0
|
作者：
Penaloza-MacMaster, Pablo A. [1 ]
Wang, Yidan [1 ]
Eitzinger, Simon [1 ]
Bhattacharyya, Mitra [1 ]
Penaloza-MacMaster, Pablo [1 ]
机构：
[1] Northwestern Univ, Evanston, IL 60208 USA
来源：
JOURNAL OF IMMUNOLOGY | 2019年 / 202卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
140.12
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination
    Finnefrock, Adam C.
    Tang, Aimin
    Li, Fengsheng
    Freed, Daniel C.
    Feng, Meizhen
    Cox, Kara S.
    Sykes, Kara J.
    Guare, James P.
    Miller, Michael D.
    Olsen, David B.
    Hazuda, Daria J.
    Shiver, John W.
    Casimiro, Danilo R.
    Fu, Tong-Ming
    JOURNAL OF IMMUNOLOGY, 2009, 182 (02): : 980 - 987
  • [22] Treg depletion enhances the antitumor effects of PD-1 blockade therapy during T cell homeostatic proliferation.
    Arita, Masashi
    Watanabe, Satoshi
    Takahashi, Miho
    Sato, Miyuki
    Shoji, Satoshi
    Ichikawa, Kosuke
    Kondo, Rie
    Tanaka, Junta
    Sakagami, Takuro
    Koya, Toshiyuki
    Kikuchi, Toshiaki
    CANCER SCIENCE, 2018, 109 : 294 - 294
  • [23] Possibility of PD-1/PD-L1 inhibitors for the treatment of patients with chronic hepatitis B infection
    Su, Menghan
    Ye, Ting
    Wu, Wei
    Shu, Zheyue
    Xia, Qi
    DIGESTIVE DISEASES, 2024, 42 (01) : 53 - 60
  • [24] mTOR regulates T cell exhaustion and PD-1 targeted immunotherapy response during chronic viral infection
    Ando, Satomi
    Perkins, Charles M.
    Sajiki, Yamato
    Chastain, Chase
    Valanparambil, Rajesh M.
    Wieland, Andreas
    Hudson, William H.
    Hashimoto, Masao
    Ramalingam, Suresh S.
    Freeman, Gordon J.
    Ahmed, Rafi
    Araki, Koichi
    JOURNAL OF CLINICAL INVESTIGATION, 2022, 132 (22):
  • [25] PD-1 blockade therapy for cancer
    Ribas, Antoni
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [26] PD-1 targeted therapy in lymphomas
    Ansell, Stephen M.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 13 - 13
  • [27] TALIMOGENE LAHERPAREPVEC ENHANCES THE EFFICACY OF PD-1 BLOCKADE
    Ribas, A.
    Dummer, R.
    Puzanov, I
    VanderWalde, A.
    Andtbacka, R. H.
    Michielin, O.
    CANCER DISCOVERY, 2017, 7 (11) : 1211 - 1211
  • [28] Radiotherapy enhances the effect of PD-1 checkpoint inhibitors
    Baumann, Rene
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 (09) : 763 - 764
  • [29] Programmed Death 1 (PD-1) and PD-1 Ligand (PD-L1) Expression in Chronic Apical Periodontitis
    Rezende Delgado, Ronan Jacques
    Ramos Pinheiro, Claudia
    Gasparoto, Thais Helena
    Sipert, Carla Renata
    de Moraes, Ivaldo Gomes
    Garcia, Roberto Brandao
    Bramante, Clovis Monteiro
    Bernardineli, Norberti
    Nishiyama, Celso Kenji
    da Silva, Joao Santana
    Torres, Sergio Aparecido
    Garlet, Gustavo Ponnpernnaier
    Campanelli, Ana Paula
    EUROPEAN ENDODONTIC JOURNAL, 2019, 4 (01): : 3 - 8
  • [30] Ubenimex enhances the antitumor effect of anti PD-1 antibody, regardless of the sensitivity of anti PD-1 antibody
    Igo, Naoko
    Nagai, Daichi
    Otake, Katsumasa
    Tomura, Arihiro
    Ichimura, Eiji
    Yokoyama, Hirofumi
    CANCER SCIENCE, 2023, 114 : 1178 - 1178
12345